Literature DB >> 11145224

Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier.

P J Gaillard1, I C van der Sandt, L H Voorwinden, D Vu, J L Nielsen, A G de Boer, D D Breimer.   

Abstract

PURPOSE: To investigate the influence of astrocytes on P-glycoprotein (Pgp) expression and intracellular accumulation of Pgp substrates, separate from their net transcellular transport across the blood-brain barrier (BBB).
METHODS: An in vitro BBB model was used, comprising of brain capillary endothelial cells (BCEC) monolayers or BCEC co-cultured with astrocytes.
RESULTS: BCEC+astrocyte co-cultures seemed to express a higher level of Pgp compared to BCEC monolayers. Inhibition of Pgp results in an increased intracellular accumulation of Pgp substrates in both BCEC monolayers and BCEC+astrocyte co-cultures, and increased the sensitivity for vinblastine mediated disruption of the in vitro BBB (called the vinblastine exclusion assay). BCEC monolayers were more sensitive to vinblastine mediated disruption compared to BCEC+astrocyte co-cultures. In the latter, but not in BCEC monolayers, an inhibitable polar transport of Pgp substrates was only found from the brain to the blood side of the filter.
CONCLUSIONS: Astrocytes increase the functional expression of Pgp in our in vitro BBB model. These results also illustrate that an important role for Pgp on the BBB is to protect the barrier against intracellular accumulation of cytotoxic BBB disrupting compounds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11145224     DOI: 10.1023/a:1026406528530

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  Brain microvascular and astrocyte localization of P-glycoprotein.

Authors:  W M Pardridge; P L Golden; Y S Kang; U Bickel
Journal:  J Neurochem       Date:  1997-03       Impact factor: 5.372

2.  Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier.

Authors:  L Fenart; V Buée-Scherrer; L Descamps; C Duhem; M G Poullain; R Cecchelli; M P Dehouck
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

3.  Localized changes in blood-brain barrier permeability following the administration of antineoplastic drugs.

Authors:  L A MacDonell; P E Potter; R A Leslie
Journal:  Cancer Res       Date:  1978-09       Impact factor: 12.701

4.  Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.

Authors:  I C van der Sandt; M C Blom-Roosemalen; A G de Boer; D D Breimer
Journal:  Eur J Pharm Sci       Date:  2000-09       Impact factor: 4.384

5.  Heterogeneity in P-glycoprotein (multidrug resistance) activity among murine peripheral T cells: correlation with surface phenotype and effector function.

Authors:  U Bommhardt; J C Cerottini; H R MacDonald
Journal:  Eur J Immunol       Date:  1994-12       Impact factor: 5.532

6.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

Authors:  A H Schinkel; E Wagenaar; C A Mol; L van Deemter
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

7.  Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.

Authors:  A M Yahanda; K M Alder; G A Fisher; N A Brophy; J Halsey; R I Hardy; M P Gosland; B L Lum; B I Sikic
Journal:  J Clin Oncol       Date:  1992-10       Impact factor: 44.544

Review 8.  P-glycoprotein and pharmacokinetics.

Authors:  D Levêque; F Jehl
Journal:  Anticancer Res       Date:  1995 Mar-Apr       Impact factor: 2.480

9.  Role of the endothelial cytoskeleton in blood-brain-barrier permeability to protein.

Authors:  S Nag
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Etoposide-induced blood-brain barrier disruption. Effect of drug compared with that of solvents.

Authors:  M K Spigelman; R A Zappulla; J Johnson; S J Goldsmith; L I Malis; J F Holland
Journal:  J Neurosurg       Date:  1984-10       Impact factor: 5.115

View more
  35 in total

Review 1.  In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Authors:  Hans C Helms; N Joan Abbott; Malgorzata Burek; Romeo Cecchelli; Pierre-Olivier Couraud; Maria A Deli; Carola Förster; Hans J Galla; Ignacio A Romero; Eric V Shusta; Matthew J Stebbins; Elodie Vandenhaute; Babette Weksler; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-11       Impact factor: 6.200

Review 2.  Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology.

Authors:  Tetsuya Terasaki; Sumio Ohtsuki
Journal:  NeuroRx       Date:  2005-01

Review 3.  In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro.

Authors:  R F Haseloff; I E Blasig; H C Bauer; H Bauer
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 4.  Strategies to improve drug delivery across the blood-brain barrier.

Authors:  Albertus G de Boer; Pieter J Gaillard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

5.  Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds.

Authors:  John P Frampton; Michael L Shuler; William Shain; Matthew R Hynd
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2008

6.  A genomic comparison of in vivo and in vitro brain microvascular endothelial cells.

Authors:  Anthony R Calabria; Eric V Shusta
Journal:  J Cereb Blood Flow Metab       Date:  2007-06-13       Impact factor: 6.200

Review 7.  3D in vitro modeling of the central nervous system.

Authors:  Amy M Hopkins; Elise DeSimone; Karolina Chwalek; David L Kaplan
Journal:  Prog Neurobiol       Date:  2014-11-22       Impact factor: 11.685

Review 8.  Developing therapeutic antibodies for neurodegenerative disease.

Authors:  Y Joy Yu; Ryan J Watts
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

9.  An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the ABC transporters, P-gp, Bcrp and Mrp-1.

Authors:  Hans Christian Helms; Maria Hersom; Louise Borella Kuhlmann; Lasina Badolo; Carsten Uhd Nielsen; Birger Brodin
Journal:  AAPS J       Date:  2014-06-17       Impact factor: 4.009

10.  Identification of peptide ligands for targeting to the blood-brain barrier.

Authors:  Inge van Rooy; Serpil Cakir-Tascioglu; Pierre-Olivier Couraud; Ignacio A Romero; Babette Weksler; Gert Storm; Wim E Hennink; Raymond M Schiffelers; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2010-02-17       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.